Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL670349 | 0.87 | — | — | |
| Iodide SCHEMBL1892715 | 0.84 | — | — | |
| Bromide SCHEMBL1893054 | 0.84 | — | — | |
| SCHEMBL4093374 | 0.81 | NOS3 (0.38) | NOS3NOS1NOS2ALDH1A1 | |
| SCHEMBL4093727 | 0.78 | ALDH1A1 (0.38) | NOS3NOS1NOS2ALDH1A1CA1 | |
| SCHEMBL4105649 | 0.78 | ALDH1A1 (0.38) | NOS3NOS1NOS2ALDH1A1CA1 | |
| SCHEMBL4105234 | 0.78 | NOS3 (0.43) | NOS3NOS1NOS2ALDH1A1 | |
| Sulfuric Acid SCHEMBL919865 | 0.77 | NOS3 (0.42) | NOS3NOS1NOS2MAPTCA1 | |
| Phosphoric Acid SCHEMBL11762462 | 0.77 | NOS3 (0.42) | NOS3NOS1NOS2MAPTCA1 | |
| SCHEMBL4105266 | 0.75 | TSHR (0.42) | NOS3NOS1NOS2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10869843-B2 | Method for increasing muscle mass and strength | CHEMI NUTRA (US) | 2020-12-22 | — | — | US | disclosed |
| EP-2852390-A1 | COMPOSITIONS AND METHODS FOR INCREASING STRENGTH AND MUSCLE MASS | Chemi Nutra Inc. (US) | 2015-04-01 | — | — | EP | disclosed |
| US-20130338114-A1 | COMPOSITIONS FOR INCREASING STRENGTH, MUSCLE MASS, AND LEAN BODY MASS | CHEMI NUTRA (US) | 2013-12-19 | — | — | US | disclosed |
| WO-2013177458-A1 | COMPOSITIONS FOR INCREASING STRENGTH, MUSCLE MASS, AND LEAN BODY MASS | CHEMI NUTRA (US) | 2013-11-28 | — | — | WO | disclosed |
| WO-2013175386-A1 | COMPOSITIONS AND METHODS FOR INCREASING STRENGTH AND MUSCLE MASS | CHEMI NUTRA INC. (US) | 2013-11-28 | — | — | WO | disclosed |
| WO-2013175266-A1 | METHOD FOR INCREASING MUSCLE MASS AND STRENGTH | CHEMI NUTRA INC. (US) | 2013-11-28 | — | — | WO | disclosed |
| US-20120141448-A1 | Method for increasing muscle mass and strength | CHEMI NUTRA, LLC | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130338114-A1 | COMPOSITIONS FOR INCREASING STRENGTH, MUSCLE MASS, AND LEAN BODY MASS | PLD1, PLD2, PLCD1 | NOS3 2056/4885NOS1 1626/4885NOS2 2173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.